Dapagliflozin Tablets
制剂 FDF · Tablets · 10mg
制剂 FDFConfidentiality：公开
- INN / Generic Name
- Dapagliflozin Tablets
- Dosage Form
- Tablets
- Strength
- 10mg
- Therapy Area
- Metabolic & Endocrinology
- Indication
- Type 2 diabetes mellitus; Symptomatic chronic heart failure with reduced ejection fraction; Chronic kidney disease (CKD); Heart failure with preserved ejection fraction; Reduction of risk of cardiovascular death in patients with type 2 diabetes mellitus
- Current Status
- 官方 FDF 授权目录（UB955）
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 已完成注册（目标市场可转移 / 视市场 DCP·NP）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —